PATIENT ALERT: Information regarding Coronavirus (COVID-19).  

Clinical Research & Trials

USO 18269

Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 200kHz) Concomitant with Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer ( ENGOT-ov50 / INNOVATE-3)

 

Disease Types: GYN Cancer Research

Available at: